Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Garzon R et al. – The data support a tumor suppressor role for miR–29b and provide a rationale for the use of synthetic miR–29b oligonucleotides as a novel strategy to improve treatment response in AML.

Today in Leukemia/Lymphoma...keeping you current

Evaluation of childhood acute leukemia incidence and underreporting in Brazil by capture-recapture methodology
Cancer Epidemiology, 12/08/09

Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?
Best Practice & Research: Clinical Haematology , 12/08/09

New agents for AML and MDS
Best Practice & Research: Clinical Haematology , 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address